Company intelligence / Profile preview

Symphera

Munich, Bavaria, Germanysymphera.io ↗

Ownership: Private
Development stage: Preclinical

Overview

Symphera has developed a prototype of an advanced surgical system that automates tool-switching during laparoscopic procedures, aiming to simplify workflows, reduce operating time, and improve post-operative outcomes. The company is currently advancing development and preparing for initial pre-clinical tests as part of the certification process.

Therapeutic areas: Other
Modalities: Device (surgical system)
Industry: Surgical Medical Devices

Partnerships

IRCAD (Institut de Recherche contre les Cancers de l’Appareil Digestif), Strasbourg

Beyond the preview

Go deeper on Symphera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Symphera.

Explore the full profile